Viatris (VTRS)
Markets established brands, complex generics, and newer innovative medicines worldwide.
$16.99
After hours−0.19 (−1.13%)
At close$17.18(+0.47%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 92.22% | 1.06B shares | |
|---|---|---|---|
| 1,062 holders · as of Jun 30, 2026 | |||
| Insiders | 0.18% | 2.09M shares | |
| 19 holders · as of Aug 18, 2026 | |||
| Other | 7.60% | 87.22M shares | |
| remainder | |||
1.15B company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
1,062 holders · 1.06B shares · 119 new positions · 487 increased · 326 reduced · 108 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 96.66M | 8.42% | +80.07M | Aug 13, 2026 |
| BlackRock, Inc. | 86.02M | 7.49% | +1.66M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 76.05M | 6.62% | +1.33M | Aug 13, 2026 |
| Davis Selected Advisers | 75.23M | 6.55% | −2.98M | Aug 11, 2026 |
| Price T Rowe Associates Inc /MD/ | 68.21M | 5.94% | +2.35M | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 54.28M | 4.73% | +370.8K | Aug 13, 2026 |
| State Street Corp | 53.07M | 4.62% | +835.8K | Aug 7, 2026 |
| Rubric Capital Management LP | 34.17M | 2.97% | +668.7K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 11.00% | 126.76M | 13G | Sep 8, 2026 |
| Vanguard Capital Management | 7.36% | 84.81M | 13G | Apr 30, 2026 |
| Davis Selected Advisers | 6.80% | 78.21M | 13G | May 5, 2026 |
| BlackRock, Inc. | 6.60% | 76.38M | 13G | Oct 17, 2025 |
| T. Rowe Price Associates, Inc. | 6.30% | 74.72M | 13G | May 14, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 25, 2026 | Paul Campbellofficer: See Remarks | Sale | 50,076 | $16.17 | 316,212 |
| Mar 23, 2026 | Paul Campbellofficer: See Remarks | Sale | 21,350 | $13.28 | 366,288 |
| Aug 27, 2025 | David S. Simmonsdirector | Purchase | 286 | $10.42 | 970 |
| Nov 3, 2025 | David S. Simmonsdirector | Purchase | 213 | $10.43 | 1,183 |
House and Senate disclosures
Not reported.